Thrombocytopenia in solid tumors: Prognostic significance
Solid tumors are a heterogeneous group of malignancies that result from out-of-control proliferation of cells. Thrombocytopenia is a common complication among patients with solid tumors that predispose them to bleeding disorders. The aim of this review article is to investigate the underlying mecha...
Main Authors: | Majid Ghanavat, Mina Ebrahimi, Hassan Rafieemehr, Mahmood Maniati, Masumeh Maleki Behzad, Saeid Shahrabi |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2019-05-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | https://www.oncologyreviews.org/index.php/or/article/view/413 |
Similar Items
-
CD markers polymorphisms as prognostic biomarkers in hematological malignancies
by: Saeid Shahrabi, et al.
Published: (2020-07-01) -
Experience of off-label use of Eltrombopag in the treatment of thrombocytopenia associated with solid tumors
by: María Henar García Lagunar, et al.
Published: (2015-02-01) -
Oxaliplatin induced acute immune-mediated thrombocytopenia; a case report
by: İsmail Beypinar, et al.
Published: (2017-04-01) -
Experimental Models of Thrombocytopenia in Laboratory Animals and their Application in Identifying the Complications of
Chemotherapy Drugs
by: H Kamali, et al.
Published: (2018-04-01) -
Value of Extracellular High Mobility Group Box 1 (HMGB1) in the Clinical Context of Immune Thrombocytopenia
by: Elif G Umit, et al.
Published: (2019-06-01)